Zentalis Pharmaceuticals Financial Overview
Zentalis Pharmaceuticals's market cap is currently $99.71M. The company's EPS TTM is $-0.37; its P/E ratio is -0.64; Zentalis Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
